We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
The Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF is an exchange traded fund listed on the Australian Securities Exchange (ASX). Its last market close was $21.89 – a decrease of 2.88% over the previous week. All prices are listed in Australian Dollars.
How to buy Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF units
Compare online brokers. To invest in exchange traded funds (ETFs) listed in Australia, you'll need to sign up to an ETF broker platform with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
Search for the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF. Find the ETF by name or ticker symbol: EMKT. Research its history to confirm it's a solid investment against your financial goals.
Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
Decide on how many to buy. At today's price of $21.89, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
Check in on your investment. Congratulations, you've invested in the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF price performance over time
Historical closes compared with the last close of A$21.89
1 week (2022-01-21)
1 month (2021-12-29)
3 months (2021-10-29)
6 months (2021-07-29)
1 year (2021-01-29)
2 years (2020-01-28)
3 years (2019-01-25)
5 years (2017-01-25)
How has coronavirus impacted the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF unit price?
Since the stock market crash in March caused by coronavirus, the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF unit price has had significant positive movement.
Its last market close was $21.89, which is 5.30% up on its pre-crash value of $20.73 and 45.93% up on the lowest point reached during the March crash when the unit price fell as low as $15.
If you had bought $1,000 worth of Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF units at the start of February 2020, those units would have been worth $840.84 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,096.25.
Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF unit price
Use our graph to track the performance of EMKT stocks over time.
Share Trading Account Offer
eToro (global stocks)
Standard brokerage - US shares
Share Trading Account Offer
Get $0 brokerage on US, Hong Kong and European stocks with trades as little as $50 when you join the world's biggest social trading network.
$0 brokerage for US, Hong Kong and European stocks
Over the last 12 months, the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF's units have ranged in value from as little as $18.55 up to $22.96. A popular way to gauge an ETF's volatility is its "beta".
Beta is a measure of volatility in relation to the market. The market (AU average) beta is 1, while Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF's is 0.97. This would suggest that the Vaneck Vectors MSCI Multifactor Emerging Markets Equity ETF is less volatile than average (for this exchange).
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
How likely would you be to recommend finder to a friend or colleague?
Very UnlikelyExtremely Likely
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Important information about this website
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.